Company / Operating Cash Flow per Share
Disc Medicine, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$5.11
FY2025
5-year range
-$40.65 / -$3.29
FY2021-FY2025
Trend
-50.2%
vs FY2024
Sector context
#200 of 212
Health Care
What the data says
Among 212 Health Care companies, Disc Medicine, Inc. is in the bottom 6% for operating cash flow per share. Declined from $-3.29 to $-5.11 over the past 2 years.
Based on SEC 10-K filings.
-5.11 in FY2025.
Declined from $-3.29 to $-5.11 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 212This company -$5.11 Sector average $5.28
▼
-196.9% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 50.2% year-over-year.
- Ranks #200 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2020.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.11 | -50.2% |
| FY2024 | -$3.40 | -3.4% |
| FY2023 | -$3.29 | +91.9% |
| FY2022 | -$40.65 | -29.7% |
| FY2021 | -$31.35 | -1348.5% |
| FY2020 | -$2.16 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026